Dr.nuell Vanishing Bb
FDA Label NDC 73430-0007

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Apharm Co., Ltd. for the product Dr.nuell Vanishing Bb (NDC 73430-0007). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, inactive ingredient, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

arbutin, adenosine, ethylhexyl methoxycinnamate, titanium dioxide

Otc - Purpose

brightening

wrinkle improvement

UV protection

Otc - Keep Out Of Reach Of Children

Keep out of reach of children

Indications & Usage

use BB cream alone, or take the appropriate amount and apply it evenly along with the skin texture in the last stage of skin care

Warnings

1) if there is any abnormal symptom or side effect, such as red spot, swelling and itching when using cosmetlcs or after using due to direct sunlight, consult dermatologists
2) Do not use for wounded areas
3) Precautions for storage and handling
keep out of reach of children, store away from direct sunlight
4) avoid the eye area

Inactive Ingredient

water, cyclopentasiloxane, dimethicone, etc.

Dosage & Administration

For external use only

Package Label.Principal Display Panel

Label (Label)

Label (Label)

* Please review the disclaimer below.